ATE493431T1 - An der oberfläche befindliche campylobacter jejuni-polypeptide - Google Patents

An der oberfläche befindliche campylobacter jejuni-polypeptide

Info

Publication number
ATE493431T1
ATE493431T1 AT04797464T AT04797464T ATE493431T1 AT E493431 T1 ATE493431 T1 AT E493431T1 AT 04797464 T AT04797464 T AT 04797464T AT 04797464 T AT04797464 T AT 04797464T AT E493431 T1 ATE493431 T1 AT E493431T1
Authority
AT
Austria
Prior art keywords
campylobacter
polypeptides
campylobacter jejuni
located polypeptides
relates
Prior art date
Application number
AT04797464T
Other languages
English (en)
Inventor
Petra Schrotz-King
Crawford Skaarup
Nielsen Nyborg
Tatyana Prokhorova
Original Assignee
Ace Biosciences As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ace Biosciences As filed Critical Ace Biosciences As
Application granted granted Critical
Publication of ATE493431T1 publication Critical patent/ATE493431T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT04797464T 2003-11-21 2004-11-19 An der oberfläche befindliche campylobacter jejuni-polypeptide ATE493431T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301726 2003-11-21
US52461703P 2003-11-25 2003-11-25
PCT/DK2004/000803 WO2005049641A2 (en) 2003-11-21 2004-11-19 Surface-located campylobacter jejuni polypeptides

Publications (1)

Publication Number Publication Date
ATE493431T1 true ATE493431T1 (de) 2011-01-15

Family

ID=43426113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04797464T ATE493431T1 (de) 2003-11-21 2004-11-19 An der oberfläche befindliche campylobacter jejuni-polypeptide

Country Status (14)

Country Link
US (1) US20070178110A1 (de)
EP (1) EP1694697B1 (de)
JP (1) JP2008501625A (de)
KR (1) KR20060129229A (de)
CN (1) CN1906210A (de)
AT (1) ATE493431T1 (de)
AU (1) AU2004291213B2 (de)
CA (1) CA2546873A1 (de)
DE (1) DE602004030824D1 (de)
DK (1) DK1694697T3 (de)
ES (1) ES2358804T3 (de)
NO (1) NO20062916L (de)
PL (1) PL1694697T3 (de)
WO (1) WO2005049641A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE545655T1 (de) * 2004-06-18 2012-03-15 Enkam Pharmaceuticals As Fgfr-bindende peptide
AU2006229549B2 (en) * 2005-03-31 2011-04-07 Leiden University Medical Center Methods and means for diagnostics, prevention and treatment of Mycobacterium infections and tuberculosis disease
CN102497875B (zh) * 2009-07-16 2014-08-20 华盛顿州立大学研究基金会 抑制空肠弯曲杆菌细菌感染的抗原组合物和方法及该抗原组合物的用途
MX350306B (es) 2010-06-09 2017-09-04 Univ Arkansas Vacuna y metodos para reducir una infeccion por campylobacter.
CN104159601B (zh) 2012-02-01 2017-05-24 代表亚利桑那大学的亚利桑那董事会 弯曲杆菌属免疫原性组合物及其用途
US10248758B2 (en) * 2013-02-07 2019-04-02 University Of Washington Through Its Center For Commercialization Self-assembling protein nanostructures
AU2014239557B2 (en) 2013-03-15 2019-01-03 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
KR102767638B1 (ko) 2016-05-03 2025-02-20 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
BR112019015425A2 (pt) 2017-01-27 2020-05-26 University Of Florida Research Foundation, Incorporated Uma vacina de segurança alimentar para controlar salmonella enterica e reduzir campylobacter em aves domésticas
EP3823727A2 (de) * 2018-07-17 2021-05-26 Humabs Biomed SA Antikörper gegen campylobacter-spezies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
NZ338039A (en) * 1997-04-01 2001-04-27 Human Genome Sciences Inc Identification of polynucleotides encoding helicobacter polypeptides in the helicobacter genome
AU3458299A (en) * 1998-03-31 1999-10-18 United States Of America, As Represented By The Secretary Of Agriculture, The Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
JP2000351735A (ja) * 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
CA2296869A1 (en) * 2000-01-24 2001-07-24 Angela Joe A surface-exposed lipoprotein to campylobacter jejuni involved in adherence to hep-2 cells
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms

Also Published As

Publication number Publication date
EP1694697B1 (de) 2010-12-29
PL1694697T3 (pl) 2011-05-31
DK1694697T3 (da) 2011-04-18
US20070178110A1 (en) 2007-08-02
WO2005049641A2 (en) 2005-06-02
KR20060129229A (ko) 2006-12-15
HK1097854A1 (en) 2007-07-06
AU2004291213B2 (en) 2011-09-08
CA2546873A1 (en) 2005-06-02
ES2358804T3 (es) 2011-05-13
JP2008501625A (ja) 2008-01-24
WO2005049641A3 (en) 2005-10-20
CN1906210A (zh) 2007-01-31
DE602004030824D1 (de) 2011-02-10
NO20062916L (no) 2006-08-21
AU2004291213A1 (en) 2005-06-02
EP1694697A2 (de) 2006-08-30

Similar Documents

Publication Publication Date Title
DK1576967T3 (da) Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse
ATE450547T1 (de) Eml4-alk-fusionsgen
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
BRPI0315666B8 (pt) dna de a34 e a33 do tipo 3, proteínas, seus anticorpos e métodos de tratamento usando os mesmos
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
HUP0500345A2 (hu) Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására
MXPA02000192A (es) Composiciones y metodos para la terapia y diagnostico de cancer de pulmon.
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
MXPA04006517A (es) Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores.
CY1108459T1 (el) Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων
ATE493431T1 (de) An der oberfläche befindliche campylobacter jejuni-polypeptide
NO20064794L (no) Anvendelse av anti-alfa5beta1-antistoffer for inhibering av kreftcelleproliferasjon
WO2005118836A3 (en) Hif prolyl hydroxylase activity assay
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
WO2007087263A3 (en) Human zip1, zinc and citrate for prostate cancer screening
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
WO2003093492A3 (en) Compositions and methods for determining susceptibility of hepatitis c virus to anti-viral drugs
TW200501988A (en) Nucleic acids, polypeptides, and methods for modulating apoptosis
AR029540A1 (es) COMPOSICIONES Y METODOS PARA EL DIAGNoSTICO Y LA TERAPIA DE CA NCER DE PULMoN
ATE479705T1 (de) Reduzierter slam abhängiger zell eintritt
WO2001073031A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
ATE505538T1 (de) Dna-vektoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties